Our results demonstrate a significantly higher frequency of cyclin D1 immunohistochemical overexpression in melanomas in comparison with the CCND1 gene amplification, which is probably related with the multiple and frequent molecular pathways, previously discussed, that lead to upregulate CCND1/cyclin D1 activity in the absence of gene amplification. The gene discussed is CCND1; the disease is melanoma.